These findings may say a lot more about a patient's long-term health than clinicians realized. 

Biotronik's Freesolve technology, which gained CE mark approval in February, is designed to maximize blood flow and minimize the post-implantation risks of stent thrombosis and target lesion revascularization.

The average physician would receive 3% higher Medicare payments next year following the update, commissioners estimate. 

The college said it emphasized that “thoughtful assessment” will be needed to address where artificial intelligence belongs on the Medicare payment schedule. 

“This approach is particularly galling since service outages have exacerbated the administrative burdens and care delays already associated with" prior authorization, AMA said. 

“Given the unprecedented magnitude of this cyberattack, and in the best interest of patients and health care providers, OCR is initiating an investigation into this incident,” states a “Dear Colleague” letter from OCR director Melanie Fontes Rainer.

"[S]ome states, including—until recently—Texas, even employ an honor-system approach, which relies on physicians to self-report. But guess what? The bad doctors tend not to do that, because they’re bad doctors."

When Boston Scientific’s coronary DCB gained approval in the United States, it was a moment the country's cardiologists had been looking forward to for years. The cardiologists who researched the device have now detailed their findings, highlighting the "unmet need" this technology is addressing.